Literature DB >> 11701484

Engineering and material considerations in islet cell transplantation.

E L Chaikof1.   

Abstract

The successful application and optimization of cell transplantation will require quantitative engineering design and analysis of cells and materials in which relevant biological processes remain complex and incompletely defined. This report primarily reviews the engineering and material considerations in islet cell transplantation, including established biological constraints and biohybrid devices for cell delivery, as well as available barrier materials and the associated processing strategies directed at the control of solute transport, barrier permeability, and host responses at the biological-material interface. Also described are current areas of investigation with particular promise as enabling technologies for accelerating the clinical effectiveness of islet cell transplantation.

Mesh:

Substances:

Year:  1999        PMID: 11701484     DOI: 10.1146/annurev.bioeng.1.1.103

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  12 in total

Review 1.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 2.  Islet Microencapsulation: Strategies and Clinical Status in Diabetes.

Authors:  Mustafa Omami; James J McGarrigle; Mick Reedy; Douglas Isa; Sofia Ghani; Enza Marchese; Matthew A Bochenek; Maha Longi; Yuan Xing; Ira Joshi; Yong Wang; José Oberholzer
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

3.  Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation.

Authors:  Herman Blomeier; Xiaomin Zhang; Christopher Rives; Marcela Brissova; Elizabeth Hughes; Marshall Baker; Alvin C Powers; Dixon B Kaufman; Lonnie D Shea; William L Lowe
Journal:  Transplantation       Date:  2006-08-27       Impact factor: 4.939

4.  Macroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation.

Authors:  Eileen Pedraza; Ann-Christina Brady; Christopher A Fraker; R Damaris Molano; Steven Sukert; Dora M Berman; Norma S Kenyon; Antonello Pileggi; Camillo Ricordi; Cherie L Stabler
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

Review 5.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

Review 6.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

7.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09

Review 8.  Immunoisolation: where regenerative medicine meets solid organ transplantation.

Authors:  Rajesh Pareta; Brian Sanders; Paurush Babbar; Tom Soker; Christopher Booth; John McQuilling; Sittadjody Sivanandane; Robert J Stratta; Giuseppe Orlando; Emmanuel C Opara
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

9.  Grafts of porcine small intestinal submucosa seeded with cultured homologous smooth muscle cells for bladder repair in dogs.

Authors:  Victor J V Rossetto; Lígia S L S da Mota; Noeme S Rocha; Hélio A Miot; Fabrizio Grandi; Cláudia V S Brandão
Journal:  Acta Vet Scand       Date:  2013-05-07       Impact factor: 1.695

10.  Protein polymer hydrogels: effects of endotoxin on biocompatibility.

Authors:  Liese N Beenken-Rothkopf; Lindsay S Karfeld-Sulzer; Xiaomin Zhang; Hermann Kissler; Sara A Michie; Dixon B Kaufman; Magali J Fontaine; Annelise E Barron
Journal:  J Biomater Appl       Date:  2012-07-24       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.